| Literature DB >> 30694079 |
Julien Favresse1, Giuseppe Lippi2, Pierre-Marie Roy3, Bernard Chatelain1, Hugues Jacqmin1, Hugo Ten Cate4, François Mullier1.
Abstract
D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of activation of coagulation and fibrinolysis, and it is routinely used for ruling out venous thromboembolism (VTE). D-dimer is increasingly used to assess the risk of VTE recurrence and to help define the optimal duration of anticoagulation treatment in patients with VTE, for diagnosing disseminated intravascular coagulation, and for screening medical patients at increased risk of VTE. This review is aimed at (1) revising the definition of D-dimer; (2) discussing preanalytical variables affecting the measurement of D-dimer; (3) reviewing and comparing assay performance and some postanalytical variables (e.g. different units and age-adjusted cutoffs); and (4) discussing the use of D-dimer measurement across different clinical settings.Entities:
Keywords: D-dimer; analytical; postanalytical; preanalytical; venous thromboembolism
Mesh:
Substances:
Year: 2018 PMID: 30694079 DOI: 10.1080/10408363.2018.1529734
Source DB: PubMed Journal: Crit Rev Clin Lab Sci ISSN: 1040-8363 Impact factor: 6.250